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so the Editor: Reports on “the transient left ventricular apical
allooning syndrome” (TLVABS) have described the peculiar, yet
haracteristic transient regional systolic dysfunction involving the
eft ventricle (LV) (1). None of these studies have reported right
entricular (RV) involvement. The goal of this study was to
etermine the prevalence and clinical impact of associated RV
ysfunction in patients with TLVABS.
From January 2002 to June 2005, 30 consecutive patients met
he proposed Mayo criteria for the clinical diagnosis of TLVABS
1) and were enrolled in the study. All patients gave permission for
he use of medical records for research purposes.
Transthoracic echocardiography was performed in the acute
etting in 25 of the 30 patients using standard echocardiographic
indows. Right ventricular systolic function was assessed visually
rom all available echocardiographic windows. Five patients un-
erwent cardiac magnetic resonance imaging within one week of
resentation.
Continuous variables were compared using a two-tailed Student
test. Differences between categorical variables were analyzed by
sing chi-square tests. A logistic regression analysis was performed
o differentiate the effect of LV ejection fraction from RV
nvolvement, with a p value 0.05 considered significant.
All 30 patients were women (mean age, 71 years; range, 43 to 88
ears) with angiographically normal coronary arteries or nonob-
tructive stenoses (50% luminal diameter stenosis).
Right ventricular function could be adequately evaluated using
tandard apical and subcostal views in all 25 patients. Significant
V dysfunction was found in 8 (group 2) of the 25 patients. In
atients with RV involvement, there was uniform involvement of
he RV apex (dyskinesis, akinesis, or severe hypokinesis) and
paring of the RV base. The midventricle was hypokinetic in six
atients of the total eight with RV involvement. Seven patients
rom group 2 had echocardiography at follow-up. These seven
atients had subsequently improvement of their LV ejection
raction (29  10% vs. 58  9%, p  0.001) and of their RV
unction as assessed visually. The inferior vena cava diameter
1.9  0.5 cm vs. 1.7  0.5 cm, p  0.83) did not change
ignificantly at follow-up, but the tricuspid regurgitation velocity
id (3.2  0.5 cm/s vs. 2.6  0.4 cm/s, p  0.037).
Seventeen patients (group 1) had normal RV function at the
ime of initial presentation. Fifteen of these 17 had repeat
chocardiography. Their LV ejection fraction improved signifi-
antly (43  14% vs. 63  9%, p  0.001), but there was no
hange in RV function, inferior vena cava diameter, or in tricuspid
alve regurgitation velocity (p  0.05).
In the five patients that underwent cardiac magnetic resonance
maging, four had severe impairment of RV systolic function
nvolving the distal (apical) segments, with two patients exhibiting
evere hypokinesis of the mid-RV segments. Only one of the five
atients had normal RV function. None of the five had delayed
adolinium enhancement, which is consistent with viable myocar-
ium and the absence of infarction. cTo evaluate the clinical and hemodynamic impact of RV
nvolvement, we compared group 1 to group 2. There was no
tatistical difference between the two groups with regard to age,
oronary artery risk factors, discharge cardiac medications, presen-
ation heart rate or blood pressure, electrocardiogram characteris-
ics, cardiac catheterization findings, and maximal troponin release
data not shown).
The echocardiographic findings and complications incurred by
oth groups are summarized in Table 1. The presentation LV
jection fraction was significantly reduced in group 2 as compared
ith group 1 but not at follow-up. The presentation tricuspid
egurgitation velocity was significantly higher in group 2 as
ompared with group 1 but not at follow-up.
Patients in group 2 required a hospitalization on average four
ays longer than patients in group 1. Complication rate also was
ignificantly higher in group 2 patients as compared with group 1.
In a logistic regression analysis that included both LV ejection
raction and RV involvement, only RV involvement was associated
ith severe congestive heart failure (i.e., New York Heart Asso-
able 1. Echocardiographic Data and Complications Incurred
or Patients Without and With RV Involvement
Patients With
No RV
Involvement
Patients
With RV
Involvement
p
Value
17 8
ge (SD), yrs 72 (11) 70 (13) 0.76
resentation LV ejection
fraction (SD)
42 (14) 29 (9) 0.021
resentation TR velocity
(SD), cm/s
2.7 (0.4) 3.2 (0.5) 0.030
resentation IVC diameter, cm 1.9 (0.6) 2.1 (0.3) 0.36
epeat LV ejection fraction
(SD)
63 (9) 58 (9) 0.23
epeat TR velocity (SD),
cm/s
2.5 (0.6) 2.6 (0.4) 0.80
epeat IVC diameter, cm 1.7 (0.6) 1.7 (0.4) 0.92
ollow-up time for repeat
echocardiography (SD),
days
61 (55) 86 (115) 0.60
ospital stay (SD), days 7 (4) 11 (5) 0.033
evere CHF 2 6 0.0016
ntubation 0 5 0.0003
ABP 0 3 0.0071
PR 0 1 0.14
evere CHF, IABP, or CPR 2 7 0.0002
V thrombus 1 0 0.48
V outflow tract obstruction 2 0 0.31
ollow-up after event (months) 19.3  13.9 7.0  6.3 0.026
ecurrence 0 1 0.14
eath 1 2 NS
HF  congestive heart failure; CPR  cardiopulmonary resuscitation; IABP 
ntra-aortic balloon pump; IVC inferior vena cava; LV left ventricular; NS not
ignificant; RV  right ventricular; TR  tricuspid valve regurgitation.iation functional class III or IV; p  0.014) and the combined
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March 7, 2006:1082–90ccurrence of severe congestive heart failure or requirement for
ntra-aortic balloon pump or cardiopulmonary resuscitation (p 
.0081).
The main and novel findings of this report are: 1) RV involve-
ent in TLVABS is common, transient, and, when present,
ortends a longer and more critical hospitalization course as
ompared with patients with isolated LV involvement; and 2) RV
nvolvement, when present, follows a similar pattern of regional
all motion abnormalities as does LV involvement in this syn-
rome.
It is now clear that RV function is one of the most useful
ndicators for patient survival in ischemic heart failure (2) and in
atients with congenital heart disease (3). In our study, we show
or the first time that RV involvement was common in patients
ith TLVABS, with approximately one-third of patients present-
ng with detectable RV dysfunction on echocardiography. Even if
e assume that all other five patients who did not have echocar-
iography at initial evaluation had normal RV function, at least
ne-quarter (8 of 30) of patients with TLVABS have RV involve-
ent. The RV involvement was transient but had a significant
mpact on hospitalization length and hemodynamic instability.
his effect was independent from the accompanying LV dysfunc-
ion. Clinicians should be aware of the possibility of RV dysfunc-
ion because it might have a significant impact on patient morbid-
ty, management, and, ultimately, outcome.
The major limitation of the study lies in its retrospective nature
nd relatively small number of patients. The echocardiograms were
btained for clinical use and specific imaging was not performed
or the assessment of RV function. In addition, although echocar-
iography is used to assess RV function, technical limitations to
maging exist because of the complexity of the RV anatomy (4).
In conclusion, in TLVABS, RV involvement is relativelyby KATP Channe
ncluding both dP/dt40 and negative dP/dt, right atrial pressure, and
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aegative impact on hospital stay and morbidity, and its identifica-
ion can help predict hemodynamic instability. Given our findings,
e propose relabeling this syndrome as “transient cardiac apical
allooning syndrome.”
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Levosimendan Improves Cardiopulmonary Resuscitation and Survival
l Activationo the Editor: Global myocardial ischemia during cardiac arrest
ccounts for post-resuscitation myocardial dysfunction (1). The
ew myofilament Ca sensitizer, levosimendan, is of potential
enefit in this setting, for it improves myocardial contractility
ithout increasing myocardial oxygen consumption (2). Experi-
entally, levosimendan produces dose-dependent increases in con-
ractility without adverse effects on diastolic function (3,4).
Levosimendan is a KATP channel opener of both plasma
embranes and mitochondria (2,5). Opening of adenosine
riphosphate (ATP)-sensitive potassium channels in ventricular
yocites contributes to the inotropic action of levosimendan (2).
ctivation of the KATP channels also mitigates myocardial
schemic injury, reminiscent of “ischemic preconditioning” during
ardiopulmonary resuscitation (6), with improved survival. We
herefore hypothesized that levosimendan would improve initial
ardiac resuscitation, post-resuscitation myocardial function, and
ost-resuscitation survival resulting from KATP channel activation.
The study was approved by the Institutional Animal Care and Use
ommittee of the Weil Institute. Fifteen male Sprague-Dawley rats
eighing between 450 and 550 g were fasted overnight. Anesthesia
ollowed intraperitoneal injection of pentobarbital in an amount of 45
g kg1. The trachea was orally intubated. Left ventricular pressure,ortic pressure were measured with polyethylene catheters (PE 50,
ecton-Dickinson, Sparks, Maryland) and with a high-sensitivity
ressure transducer (model 42584-01, Abbott Critical Care System,
orth Chicago, Illinois). A thermocouple microprobe (9030-12-D-
4, Columbus Instrument, Columbus, Ohio) was advanced into the
escending thoracic aorta for blood temperature measurements. For
ardiac output measurements, 0.2 ml of isotonic saline, maintained at
0°C, was injected into the right atrium. Thermodilution curves
ere computed (CO-100, Weil Institute of Critical Care
edicine, Rancho Mirage, California). A pre-curved guide wire
as advanced through a 4-F catheter into the right ventricle until
n endocardial electrogram was observed. Forty-five minutes
efore the induction of cardiac arrest, five animals were random-
zed to pre-treatment with a bolus injection of glibenclamide into
he right atrium (6). A 60-Hz direct current, to a maximum of 3.5
A, was delivered to the right ventricular endocardium until
entricular fibrillation (VF) was induced. Current flow was then
ontinued for 3 min such as to prevent spontaneous defibrillation.
entricular fibrillation was untreated for 6 min. Pre-cordial com-
ressions at a rate of 200/min were started after 6 min, with a
neumatically driven mechanical chest compressor, and animals
ere mechanically ventilated with a tidal volume of 0.65 ml/100 gnimal body weight, a frequency of 100/min, and FiO2 of 1.0.
